Bernadette Pignol

Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression

Moin U. Fareed, Amy Evenson, Wei Wei et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2006 · 134 citations

Life Sciences, Biochemistry, Physiology +16

BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy

Pierre‐Etienne Chabrier, Michel Auguet, B. Spinnewyn et al. · Proceedings of the National Academy of Sciences · 1999 · 126 citations

Medicine, Neuroscience, Pharmacology +16

Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether]: Reversal by a specific antagonist, BN 52021

Marek Rola‐Pleszczynski, Bernadette Pignol, C. Pouliot et al. · Biochemical and Biophysical Research Communications · 1987 · 80 citations

Medicine, Immunology, Pharmacology +10

Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes

Bernadette Pignol, S. Hénane, Jean‐Michel Mencia‐Huerta et al. · Prostaglandins · 1987 · 76 citations

Medicine, Immunology, Pharmacology +9

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

Rosa Burdi, Maria Paola Didonna, Bernadette Pignol et al. · Neuromuscular Disorders · 2006 · 48 citations

Medicine, Medicinal Chemistry, Pharmacology +6